Baird Financial Group, Inc. Baxter International Inc Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 255,789 shares of BAX stock, worth $8.75 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

255,789

Previous 233,866 9.37%

Holding current value

$8.75 Million

Previous $10 Million 14.4%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$32.87 - $43.55 $720,609 - $954,746	21,923 Added 9.37%	255,789 $8.56 Million
Q1 2024 May 14, 2024	BUY	$37.88 - $43.77 $2.17 Million - $2.51 Million	57,402 Added 32.53%	233,866 $10 Million
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $2.55 Million - $3.14 Million	80,514 Added 83.91%	176,464 $6.82 Million
Q3 2023 Nov 13, 2023	BUY	$37.32 - $49.29 $44,597 - $58,901	1,195 Added 1.26%	95,950 $3.62 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $4.59 Million - $5.47 Million	-114,707 Reduced 54.76%	94,755 $4.32 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $317,701 - $444,426	8,454 Added 4.21%	209,462 $8.5 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $126,355 - $156,712	-2,346 Reduced 0.87%	265,850 $14.3 Million
Q2 2022 Aug 08, 2022	SELL	$63.83 - $80.0 $582,576 - $730,160	-9,127 Reduced 3.29%	268,196 $17.2 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $748,442 - $871,153	9,739 Added 3.64%	277,323 $21.5 Million
Q4 2021 Feb 09, 2022	SELL	$74.57 - $87.19 $38,925 - $45,513	-522 Reduced 0.19%	267,584 $23 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $741,167 - $840,029	10,047 Added 3.89%	268,106 $21.6 Million
Q2 2021 Aug 11, 2021	BUY	$80.5 - $88.01 $724 - $792	9 Added 0.0%	258,059 $20.8 Million
Q1 2021 May 13, 2021	BUY	$76.38 - $86.03 $822,994 - $926,973	10,775 Added 4.36%	258,050 $21.8 Million
Q4 2020 Feb 11, 2021	SELL	$75.39 - $82.36 $405,673 - $443,179	-5,381 Reduced 2.13%	247,275 $19.8 Million
Q3 2020 Nov 12, 2020	BUY	$78.33 - $90.73 $4.12 Million - $4.77 Million	52,551 Added 26.26%	252,656 $20.3 Million
Q2 2020 Oct 22, 2020	BUY	$78.66 - $94.14 $5.75 Million - $6.88 Million	73,053 Added 57.5%	200,105 $17.2 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $729,256 - $872,771	-9,271 Reduced 6.8%	127,052 $10.6 Million
Q1 2020 May 14, 2020	SELL	$71.57 - $93.3 $1.73 Million - $2.26 Million	-24,240 Reduced 15.1%	136,323 $11.1 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $1.25 Million - $1.44 Million	-16,312 Reduced 9.22%	160,563 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $7,163 - $7,900	-88 Reduced 0.05%	176,875 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $1.69 Million - $1.9 Million	23,023 Added 14.96%	176,963 $14.5 Million
Q1 2019 May 14, 2019	BUY	$64.48 - $81.31 $1.56 Million - $1.97 Million	24,229 Added 18.68%	153,940 $12.5 Million
Q4 2018 Feb 14, 2019	BUY	$61.45 - $77.8 $1.61 Million - $2.04 Million	26,244 Added 25.36%	129,711 $8.54 Million
Q3 2018 Nov 13, 2018	BUY	$70.71 - $77.75 $598,065 - $657,609	8,458 Added 8.9%	103,467 $8.05 Million
Q2 2018 Aug 13, 2018	SELL	$63.43 - $75.41 $112,144 - $133,324	-1,768 Reduced 1.83%	95,009 $7.01 Million
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $1.06 Million - $1.22 Million	-16,904 Reduced 14.87%	96,777 $6.29 Million
Q4 2017 Feb 09, 2018	BUY	$61.45 - $66.05 $58,500 - $62,879	952 Added 0.84%	113,681 $7.35 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $31,178 - $33,855	524 Added 0.47%	112,729 $7.07 Million
Q2 2017 Aug 14, 2017	BUY	N/A	112,205	112,205 $6.79 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Baxter International Inc Transaction History